Currently, the only dual GLP-1/GIP receptor agonist available is Mounjaro
Health care providers often prescribe coaching to support necessary behavior changes
Mounjaro (tirzepatide) is a self-injectable treatment used for weight loss and type 2 diabetes, helping control blood sugar and reduce appetite
After administration, the hydrogel displays lens-like adhesion to corneal defects and establishes a localized drug depot, which effectively inhibits corneal fibrosis and scar formation of fungal keratitis (164)
This non-essential amino acid plays a part in the body's ability to metabolize long-chain fatty acids
As with all shared decisions, we can start by providing objective information and using a STEPS approach, which outlines a medication's safety, tolerability, effectiveness, price, and simplicity